Ledger.Open graph →
SEC Form D · filed September 2, 2021

Appili Therapeutics Inc

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HALIFAX, Nova Scotia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Theresa C. Matkovits · HALIFAX, Nova Scotia, CanadaDirectorArmand C. Balboni · HALIFAX, Nova Scotia, CanadaExec · DirectorJuergen C. Froehlich · HALIFAX, Nova Scotia, CanadaDirectorBrian M. Bloom · HALIFAX, Nova Scotia, CanadaDirectorIan C. Mortimer · HALIFAX, Nova Scotia, CanadaDirectorKimberly D. Stephens · HALIFAX, Nova Scotia, CanadaExecWarren A. Kirshenbaum · Newton, MADirectorLouis J. Decesare, Jr · Philadelphia, PADirectorPaul D. Rutkowski · Philadelphia, PAExecJill K. Jinks · Philadelphia, PAExec · DirectorRobert N. Nix, Iii · Philadelphia, PADirectorCharles B. Crawford, Jr · Philadelphia, PADirectorRochelle C. Stenzler · HALIFAX, Nova Scotia, CanadaDirectorJoseph P. Bramante · Houston, TXDirectorChristopher Trosper · West Des Moines, IADirectorMichael Quinlivan · London, United KingdomDirectorJoshua Fremed · New York, NYDirectorRobert A. Bettigole · New Haven, CTExecStephen Strittmatter · Durham, CTExec · DirectorRochelle C. Stenzler · HALIFAX, Nova Scotia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗